Rosemary Mazanet - 14 Feb 2022 Form 3 Insider Report for Columbia Care Inc. (CBSTF)

Role
Chief Scientific Officer
Signature
/s/ David Sirolly as attorney-in-fact for Rosemary Mazanet
Issuer symbol
CBSTF
Transactions as of
14 Feb 2022
Net transactions value
$0
Form type
3
Filing time
14 Feb 2022, 17:29:23 UTC
Previous filing
27 May 2021
Next filing
14 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CCHWF Common Shares 1,206,454 14 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CCHWF Proportionate Voting Shares 14 Feb 2022 Common Shares 187 $0.000000 Direct F1
holding CCHWF Restricted Stock Units 14 Feb 2022 Common Shares 42,024 Direct F2, F3
holding CCHWF Restricted Stock Units 14 Feb 2022 Common Shares 38,064 Direct F3, F4
holding CCHWF Restricted Stock Units 14 Feb 2022 Common Shares 43,535 Direct F3, F5
holding CCHWF Resricted Stock Units 14 Feb 2022 Common Share 164,327 Direct F3, F6
holding CCHWF Restricted Stock Units 14 Feb 2022 Common Shares 72,684 Direct F3, F7
holding CCHWF Performance Stock Units 14 Feb 2022 Common Shares 87,069 Direct F8
holding CCHWF Performance Stock Units 14 Feb 2022 Common Shares 87,070 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each proportionate voting shares is convertible into 100 common shares of the Issuer. The proportionate voting shares vest on March 31, 2022.
F2 168,094 restricted stock units ("RSUs") were granted on September 28, 2018, with 126,070 RSUs vesting prior to the date of this Form 3. The remaining 42,024 RSUs will vest on March 31, 2022. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4 76,127 restricted stock units ("RSUs") were granted on September 28, 2018, with 38,063 RSUs vesting prior to the date of this Form 3. The remaining 38,064 RSUs vest as follows: 19,032 on April 29, 2022 and April 29, 2023. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F5 174,139 restricted stock units ("RSUs") were granted on April 29, 2019, with 130,604 RSUs vesting prior to the date of this Form 3. The remaining 43,535 RSUs will vest on October 29, 2022. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F6 219,102 restricted stock units ("RSUs") were granted on March 31, 2020, with 54,775 RSUs vesting prior to the date of this Form 3. The remaining 164,327 RSUs will vest as follows: 54,776 on March 31, 2022 and March 31, 2024, and 54,775 on March 31, 2023. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F7 The restricted stock units ("RSUs") were granted on March 23, 2021, and vest as follows: 18,171 RSUs on March 23, 2022, March 23, 2023, March 23, 2024 and March 23, 2025. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F8 The performance stock units ("PSUs") were granted on April 29, 2019. Each PSU represents a contingent right to receive one share of the Issuer's common stock. The PSUs vest upon the Issuer's common stock achieving a specified price per share.

Remarks:

Exhibit 24.1 Power of Attorney